| Company Name | Amount Raised | Type of Fundraise | Country | Date |
| Private company financings | ||||
| VelaVigo | $60 million | Pre-A+ funding | China | 28 July |
| MapLight Therapeutics | $372.5 million | Series D | US | 28 July |
| Artbio | $132 million | Series B | US | 28 July |
| Chai Discovery | $70 million | Series A | US | 6 August |
| Minghui Pharmaceutical | $131 million | Pre-IPO round | China | 7 August |
| Strand Therapeutics | $153 million | Series B | US | 7 August |
| Kriya Therapeutics | $313 million | N/A | US | 18 August |
| Arnatar Therapeutics | $52 million | Series A | US | 25 August |
| Wugen | $115 million | Pivotal study funding | US | 27 August |
| Plexium | $60 million | Phase 1 funding | US | 28 August |
| Shenandoah Therapeutics | $21.5 million | Seed round | US | 28 August |
| Patient Square | $3.1 billion | Close of latest fund | US | 29 August |
| CHARM Therapeutics | $80 million | Series B | UK | 2 September |
| Public company financings | ||||
| Omeros Corp | $22 million | Public offering | US | 25 July |
| Lyell Immunopharma | $50 million | Private placement | US | 25 July |
| ImmunityBio | $80 million | Public offering | US | 25 July |
| ImageneBio | $57.4 million | Private placement | US | 25 July |
| I-MAB Biopharma Co., Ltd | $65 million | Public offering | US | 1 August |
| Shattuck Labs | $45.7 million | Private placement | US | 8 August |
| Assembly Biosciences | $130.0 | Public offering | US | 8 August |
| OXB | £60 million | Placing and Subscription | UK | 15 August |